I think it would be nice if we had more control over the market end of the game. Currently it seems a bit unfair in some aspects, for example, if you’re putting out an obviously superior product, but can’t directly hike your selling price to take advantage of this. If I’m putting out a drug that has no side effects, is more refined and stronger than the competition, I want to be able to point this out in the form of advertising, which would affect the market for a period. I also expect that, if I have a good product, (eg B+) and my competition is a bad one (eg D-), the disparity in prices should be more pronounced, there could also be market events which see the lesser products completely devalued in the eyes of the public. This would actually present the player with a strategy of either making a quick buck at higher risk, or investing in a better product for more long term security and potential gains.
Although of course there needs to be some element of uncertainty, it doesn’t seem like there’s enough incentive to produce more than just the bare minimum of drug with all their side effects intact, since your operating costs eat up too much of your profit, especially early game. Even if you research improvements on the machines which bring down the process costs, you’ve actually spent money on the salaries of the researchers during that period, which means that you’re not really standing to recoup much by reducing the price of a drug by say $10, when it cost over $1000 to achieve that cost reduction. Plus the initial investment in machines. Plus the cost of taking out a loan. Etc etc.
Altogether it seems like actual profit is not really achievable unless you play the game for decades, due to the low value of drugs on the market, high investment and low starting capital. It’s just a bit frustrating that the AI takes the cheap and easy route and makes more profit with sub-standard products, and there’s not really much I can do about this - there should be.